BCTX Briacell Therapeutics Corp

USD 2.67 0.13 5.11811
Icon

Briacell Therapeutics Corp (BCTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.67

+0.13 (+5.12)%

USD 0.05B

0.09M

USD 19.00(+611.61%)

USD 10.33 (+286.89%)

Icon

BCTX

Briacell Therapeutics Corp (USD)
COMMON STOCK | NSD
USD 2.67
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.05B

USD 10.33 (+286.89%)

USD 2.67

Briacell Therapeutics Corp (BCTX) Stock Forecast

Show ratings and price targets of :
USD 19.00
(+611.61%)

Based on the Briacell Therapeutics Corp stock forecast from 1 analysts, the average analyst target price for Briacell Therapeutics Corp is USD 19.00 over the next 12 months. Briacell Therapeutics Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Briacell Therapeutics Corp is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Briacell Therapeutics Corp’s stock price was USD 2.67. Briacell Therapeutics Corp’s stock price has changed by +19.20% over the past week, -22.16% over the past month and -62.76% over the last year.

No recent analyst target price found for Briacell Therapeutics Corp
No recent average analyst rating found for Briacell Therapeutics Corp

Company Overview Briacell Therapeutics Corp

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibi...Read More

https://briacell.com

Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1

16

July

USD

USA

Adjusted Closing Price for Briacell Therapeutics Corp (BCTX)

Loading...

Unadjusted Closing Price for Briacell Therapeutics Corp (BCTX)

Loading...

Share Trading Volume for Briacell Therapeutics Corp Shares

Loading...

Compare Performance of Briacell Therapeutics Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BCTX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Briacell Therapeutics Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing BCTX

Symbol Name BCTX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Briacell Therapeutics Corp (BCTX) Stock

Based on ratings from 1 analysts Briacell Therapeutics Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on BCTX's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for BCTX is USD 19.00 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 18.

BCTX stock's Price/Earning ratio is 745.00. Our analysis grades BCTX stock's Price / Earning ratio at F. This means that BCTX stock's Price/Earning ratio is above 98% of the stocks in the Biotechnology sector in the NSD exchange. Based on this BCTX may be a overvalued for its sector.

The last closing price of BCTX's stock was USD 2.67.

The most recent market capitalization for BCTX is USD 0.05B.

Based on targets from 1 analysts, the average taret price for BCTX is projected at USD 19.00 over the next 12 months. This means that BCTX's stock price may go up by +611.61% over the next 12 months.

We can't find any ETFs which contains Briacell Therapeutics Corp's stock.

As per our most recent records Briacell Therapeutics Corp has 16 Employees.

Briacell Therapeutics Corp's registered address is Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1. You can get more information about it from Briacell Therapeutics Corp's website at https://briacell.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...